This company seems to have been delisted
Reason: Acquired by CSL
Last recorded trade on: February 23, 2023
Source: https://www.fiercepharma.com/pharma/csl-agrees-to-11-7-billion-deal-to-acquire-vifor-largest-m-a-deal-year
Reason: Acquired by CSL
Last recorded trade on: February 23, 2023
Source: https://www.fiercepharma.com/pharma/csl-agrees-to-11-7-billion-deal-to-acquire-vifor-largest-m-a-deal-year
Vifor Pharma
VIFN.SW
$239.38
Share price
0.48%
Change (1 day)
0.82%
Change (1 year)
Categories
Vifor Pharma (VIFN.SW) - Cash on Hand
Cash on Hand as of December 2021 : S$1.45 Billion
According to Vifor Pharma's latest financial reports the company has S$1.45 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vifor Pharma - Cash on Hand chart (from 2009 to 2021)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | S$1.47 B | 33.4% |
| 2020-12-31 | S$1.10 B | 45.31% |
| 2019-12-31 | S$0.75 B | 36.41% |
| 2018-12-31 | S$0.55 B | -4.78% |
| 2017-12-31 | S$0.58 B | 124.52% |
| 2016-12-31 | S$0.26 B | -57% |
| 2015-12-31 | S$0.60 B | 89.7% |
| 2014-12-31 | S$0.31 B | 3.4% |
| 2013-12-31 | S$0.30 B | -35.21% |
| 2012-12-31 | S$0.47 B | -0.16% |
| 2011-12-31 | S$0.47 B | 15.49% |
| 2010-12-31 | S$0.41 B | 357.17% |
| 2009-12-31 | S$90.28 M | -30.87% |
| 2008-12-31 | S$0.13 B | 88.31% |
| 2007-12-31 | S$69.34 M | -51.63% |
| 2006-12-31 | S$0.14 B | 189.81% |
| 2005-12-31 | S$49.47 M | -32.91% |
| 2004-12-31 | S$73.73 M | -50.91% |
| 2003-12-31 | S$0.15 B | -22.13% |
| 2002-12-31 | S$0.19 B |